DD
DuPont
2.0%
0.0%
$45.26
$45.26
Why This Position Exists
DuPont's portfolio transformation from chemical conglomerate to focused healthcare/water/industrial company is supported by the prediction ensemble, with 4 of 7 markets leaning toward outcomes that validate the transformation thesis. At $45.26, the stock has recovered modestly from the $42.44 thesis assessment price but still appears to embed more skepticism than the ensemble's probabilities justify. The strong model agreement across all markets (0.88-0.93) and the contained PFAS tail risk (17% probability) support opening a position at quarter-Kelly sizing.
Trigger: Initial thesis assessment generated 2026-03-23 classified DD as price-below-value with MEDIUM confidence. No prior position exists. The stock's ~31% decline from highs appears to overcorrect for a company with 63% probability of hitting $2.25 EPS, 69% probability of Q1 beat, and only 17% probability of catastrophic PFAS liability.
Key Market Signals
Committee Verdict
The Portfolio Analyst identified a genuine price-below-value opportunity in DD's portfolio transformation, supported by 4 of 7 markets leaning constructive with consistently high model agreement (0.88-0.93). The Risk Manager's quarter-Kelly computation produces a 2.0% weight — the minimum position size — reflecting the MEDIUM confidence and moderate magnitude correctly. The Devil's Advocate raised valid concerns about PFAS tail risk understatement, incomplete lens coverage, and near-coin-flip operational markets, but assessed the thesis as robust overall. The 2.0% position size provides substantial downside protection: even a 20% adverse move produces only a 0.4% portfolio impact, well within tolerance for a thesis that is structurally supported by contained tail risk and near-term earnings catalyst.
Devil's Advocate
thesis robustThe challenges are real but appropriately addressed by the combination of quarter-Kelly sizing and the modest 2.0% target weight. The PFAS tail risk is genuine but the 17% probability is reasonable given judicial timelines. The operational coin-flip markets reflect honest uncertainty rather than a thesis flaw. The 2.0% position size means even the worst-case bear scenario (20% loss) produces only a 0.4% portfolio impact. The thesis has genuine structural support from the PFAS containment signal and Q1 beat probability, and the small position size provides adequate buffer for the uncertainties identified.
Notable Dissent
Devil's Advocate noted that the PFAS 17% probability may understate true tail risk given the inherently unpredictable nature of environmental litigation — this is a valid concern but the small position size (2.0%) provides adequate buffer. The incomplete lens coverage (5 of 14) was also flagged; while not decision-changing at this size, a fuller analysis would strengthen conviction for any future position increase.
Monitoring Triggers
• Re-evaluate on Q1 2026 earnings release (expected late April / early May 2026) — this is the first clean quarter for the transformed company
• Re-evaluate if PFAS liability market probability rises above 30% on any new litigation development
• Re-evaluate if organic growth market drops below 40%, which would signal deteriorating execution confidence
• Mandatory review if position return drops below -15%
• Staleness review if no thesis update within 60 days (by 2026-05-23)
Position Details
Mar 27, 2026
44
price-below-value
MEDIUM
Industrials
1
Kelly Sizing Breakdown
EDGE
ODDS
KELLY
Trade History
| Date | Action | Shares | Price | Weight | Rationale |
|---|---|---|---|---|---|
| Mar 27, 2026 | OPEN | 44 | $45.26 | 0.0% → 2.0% | Portfolio transformation with 4 of 7 markets leaning constructive and consistently high model agreement (0.88-0.93). Contained tail risk (PFAS at 17%), near-term earnings catalyst (Q1 2026). Industrials sector diversification to Technology-heavy portfolio. |
Full Committee Transcripts (1)
Complete 4-step discourse records — expand each step to see the full reasoning from analyst, risk manager, devil's advocate, and committee chair.